Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Accumulated Depreciation & AmortizationAccumulated Depreciation & AmortizationLeasesLong-Term Debt RepaymentsMachine, Furnitures, Fixtures & OtherOther Gross PP&E AdjustmentsOther Gross PP&E AdjustmentsProperty, Plant & Equipment (Gross)Property, Plant & Equipment (Gross)Receivables - OtherShares IssuedShares OutstandingShares Outstanding
Ratios

Kezar Life Sciences (KZR) Accumulated Depreciation & Amortization (2021 - 2025)

Kezar Life Sciences (KZR) has disclosed Accumulated Depreciation & Amortization for 5 consecutive years, with $897000.0 as the latest value for Q4 2025.

  • For Q4 2025, Accumulated Depreciation & Amortization fell 13.75% year-over-year to $897000.0; the TTM value through Dec 2025 reached $897000.0, down 13.75%, while the annual FY2025 figure was $897000.0, 13.75% down from the prior year.
  • Accumulated Depreciation & Amortization hit $897000.0 in Q4 2025 for Kezar Life Sciences, up from $721000.0 in the prior quarter.
  • Across five years, Accumulated Depreciation & Amortization topped out at $5.1 million in Q3 2023 and bottomed at $251000.0 in Q1 2025.
  • Average Accumulated Depreciation & Amortization over 5 years is $2.4 million, with a median of $2.0 million recorded in 2021.
  • Year-over-year, Accumulated Depreciation & Amortization soared 31.25% in 2022 and then crashed 94.65% in 2024.
  • Kezar Life Sciences' Accumulated Depreciation & Amortization stood at $3.7 million in 2021, then crashed by 71.99% to $1.0 million in 2022, then increased by 4.2% to $1.1 million in 2023, then fell by 2.44% to $1.0 million in 2024, then dropped by 13.75% to $897000.0 in 2025.
  • According to Business Quant data, Accumulated Depreciation & Amortization over the past three periods came in at $897000.0, $721000.0, and $494000.0 for Q4 2025, Q3 2025, and Q2 2025 respectively.